Frontiers in Immunology, 2026 Longitudinal plasma proteomics identifies diagnostic and response-associated inflammatory and immune biomarkers in psoriasis following secukinumab therapy
Zhang H., Yang R., Ma Y. et al.
Olink Target 96 Dermatological Diseases Immunological & Inflammatory Diseases Pathophysiology Plasma
Dermatological Diseases Immunological & Inflammatory Diseases Pathophysiology Plasma
Emerging Contaminants, 2026 Alternative plasticizers induced immunotoxicity in THP-1 macrophages via mitochondrial dysfunction-driven metabolic reprogramming
Zheng S., Zhao B., Lin X. et al.
Olink Target 96 Environmental Health & Toxicology Pathophysiology Cell Culture Lysate
Environmental Health & Toxicology Pathophysiology Cell Culture Lysate
Journal of the American Society of Nephrology, 2026 RARRES1 Promotes Tubular Fibrosis via the KHDRBS1/Src/p-STAT3 Axis
Ye L., Jiang Z., Wu Y. et al.
Olink Explore 3072/384 Nephrology Pathophysiology Plasma
Nephrology Pathophysiology Plasma
Medicine, 2026 Association of genetically determined plasma hepatocyte growth factor with lung cancer and its subtypes: Mendelian randomization and mediation analysis
Xu F., Xu Q., Yu J. et al.
Olink Target 96 Oncology Pathophysiology Plasma
Oncology Pathophysiology Plasma
Translational Psychiatry, 2026 Plasma proteome profiling identifies novel biomarkers and predictors for schizophrenia
Wu S., Guo X., Jia T. et al.
Olink Explore 3072/384 Neurology Patient Stratification Plasma
Neurology Patient Stratification Plasma
Global Insights in Medicine and Nursing, 2026 Bidirectional Mendelian Randomization Reveals IL-17C as a Protective Factor and Sepsis-Induced Inflammatory Protein Dynamics
Wang J., Chen Z., Zhang Y. et al.
Olink Target 96 Immunological & Inflammatory Diseases Patient Stratification Plasma
Immunological & Inflammatory Diseases Patient Stratification Plasma
Clinical Rheumatology, 2026 Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sjögren’s syndrome to total risk non-Hodgkin lymphoma
Wang H., Yan H., Yang M. et al.
Olink Target 96 Oncology Immunological & Inflammatory Diseases Pathophysiology Plasma
Oncology Immunological & Inflammatory Diseases Pathophysiology Plasma
Immunity, 2026 Skin inflammation and itch response are independently regulated by distinct nociceptor subsets
Voisin T., Gheziel N., El Samrout C. et al.
Olink Target 48 Mouse Dermatological Diseases Pathophysiology Mouse Tissue Lysate
Dermatological Diseases Pathophysiology Mouse Tissue Lysate
Archives of Gerontology and Geriatrics, 2026 Hepatic dysfunction and long-term risk of neurodegenerative diseases: A UK Biobank-based analysis
Su W., Duan Q., He S. et al.
Olink Explore 3072/384 Neurology Hepatology Pathophysiology Plasma
Neurology Hepatology Pathophysiology Plasma
eBioMedicine, 2026 Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap
Stinson S., Shadrin A., Rahman Z. et al.
Olink Explore 3072/384 Metabolic Diseases Neurology Pathophysiology Plasma
Metabolic Diseases Neurology Pathophysiology Plasma
eBioMedicine, 2026 Blood-based biomarker discovery for early pregnancy loss using integrative multi-omics strategies
Shi Y., Yang Y., Guo X. et al.
Olink Target 96 Obstetrics Pathophysiology Patient Stratification Serum
Obstetrics Pathophysiology Patient Stratification Serum
ERJ Open Research, 2026 Systemic and local lymph node inflammation at disease onset in sarcoidosis patients
Robert M., Boizeau L., Cappy P. et al.
Olink Target 48 Immunological & Inflammatory Diseases Pathophysiology Plasma
Immunological & Inflammatory Diseases Pathophysiology Plasma
Cancer Pathogenesis and Therapy, 2026 Genetically predicted inflammatory mediators link mitochondrial function to breast cancer risk: A Mendelian randomization study
Ran L., Feng J., Chen J. et al.
Olink Target 96 Oncology Pathophysiology Plasma
Oncology Pathophysiology Plasma
PLOS One, 2026 Serum proteomic changes in atopic dermatitis patients treated with cyclosporine
Olydam J., Litman T., Nijsten T. et al.
Olink Explore 3072/384 Immunological & Inflammatory Diseases Dermatological Diseases Pathophysiology Serum
Immunological & Inflammatory Diseases Dermatological Diseases Pathophysiology Serum
Genome Medicine, 2026 Maternal-prenatal gut microbiome-systemic metabolome perturbations and TH2-skewed immunity link to offspring gut microbiome disruption and atopic dermatitis susceptibility
Ng D., Yap G., Tay C. et al.
Olink Target 96 Immunological & Inflammatory Diseases Obstetrics Pathophysiology Serum
Immunological & Inflammatory Diseases Obstetrics Pathophysiology Serum
Open Forum Infectious Diseases, 2026 Proteomic Profile After Intervention With Eplerenone Among Persons With HIV
Murthy A., Kolossváry M., Walpert A. et al.
Olink Target 96 CVD Infectious Diseases Pathophysiology Plasma
CVD Infectious Diseases Pathophysiology Plasma
MedComm, 2026 Identification of Blood Pressure‐Associated Metabolites by Integrating Metabolomic and Genetic Analysis
Liu Y., Cheng C., Pan X. et al.
Olink Explore 3072/384 CVD Pathophysiology Plasma
CVD Pathophysiology Plasma
Archives of Gerontology and Geriatrics, 2026 Plasma proteins mediate the protective association between physical activity and osteoporosis risk: A prospective study in the UK biobank
Liu B., Luo S., Geng Z. et al.
Olink Explore 3072/384 Orthopedics Pathophysiology Plasma
Orthopedics Pathophysiology Plasma
European Journal of Preventive Cardiology, 2026 Cardiovascular health across childhood and adolescence and proteomic biomarkers in late adolescence
Lin Z., Rifas-Shiman S., de Ferranti S. et al.
Olink Target 96 CVD Patient Stratification Plasma
CVD Patient Stratification Plasma
Nature Medicine, 2026 Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes
Li C., Richards S., Quinn G. et al.
Olink Explore 3072/384 Nephrology Cross-platform Validation Plasma
Nephrology Cross-platform Validation Plasma